BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 22, 2011
View Archived Issues
Phase I data presented on MLN-9708 in multiple myeloma
Read More
Plerixafor is beneficial in patients with myelokathexis
Read More
PNB-01 is superior to citalopram in phase II trial in major depressive disorder
Read More
New inhibitors claimed of mitochondrial cytochrome P450 11B1 and 11B2
Read More
Novartis researchers synthesize new neprilysin inhibitors
Read More
Palatin Technologies discloses novel melanocortin MC1 receptor agonists
Read More
New NADPH oxidase 1, dual oxidase 2 and NADPH oxidase 3 inhibitors claimed
Read More
AstraZeneca claims new antagonists of P2X3 receptor and/or P2X2/3 heterodimer
Read More
Merck & Co. patents new GPR119 receptor agonists
Read More
MK-0916 reduces HbA1c and body weight in phase II trial in diabetes/metabolic syndrome
Read More
IBC Generium licenses rights in Russia to Affitech AT-001 antibody
Read More
FDA approves new tamper-resistant immediate-release oxycodone product Oxecta
Read More
EMA committee accepts for review PROLOR's PIP for long-acting human growth hormone
Read More
Pfizer discloses phase I data on PF-03084014 and PF-04554878 in solid tumors
Read More
MAb hu3S193 stabilizes disease in phase II trial in ovarian, peritoneal and fallopian tube cancer
Read More
Lead compound selected in Concert Pharmaceuticals/GSK HIV-PI collaboration
Read More
FDA removes clinical hold on SNS01-T IND in multiple myeloma
Read More
Concert Pharmaceuticals advances new drug candidates in kidney disease and spasticity
Read More
AVI BioPharma starts phase I trial of flu therapy AVI-7100
Read More
Cebix advances C peptide replacement therapy for chronic complications of diabetes
Read More
Topline phase III data show Lyrica efficaciously reduces neuropathic pain after spinal cord injury
Read More
Bristol-Myers Squibb to make milestone payment to Alder Biopharmaceuticals
Read More
Once-weekly exenatide approved in E.U. for type 2 diabetes
Read More
Jubilant and Endo Pharmaceuticals achieve third milestone in joint oncology program
Read More
Phase III LCP-Tacro trial in stable kidney transplant recipients meets primary endpoints
Read More
Lipid Therapeutics' phase IIb trial of LT-02 in ulcerative colitis meets primary endpoint
Read More